 | Up a level |
Black, Dennis M; Reid, Ian R; Boonen, Steven; Bucci-Rechtweg, Christina; Cauley, Jane A; Cosman, Felicia; Cummings, Steven R; Hue, Trisha F; Lippuner, Kurt; Lakatos, Peter; Leung, Ping Chung; Man, Zulema; Martinez, Ruvie Lou Maria; Tan, Monique; Ruzycky, Mary Ellen; Su, Guoqin; Eastell, Richard (2012). The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). Journal of bone and mineral research, 27(2), pp. 243-54. Hoboken, N.J.: Wiley-Blackwell 10.1002/jbmr.1494
Boonen, Steven; Reginster, Jean-Yves; Kaufman, Jean-Marc; Lippuner, Kurt; Zanchetta, Jose; Langdahl, Bente; Rizzoli, Rene; Lipschitz, Stanley; Dimai, Hans Peter; Witvrouw, Richard; Eriksen, Erik; Brixen, Kim; Russo, Luis; Claessens, Frank; Papanastasiou, Philemon; Antunez, Oscar; Su, Guoqin; Bucci-Rechtweg, Christina; Hruska, Josef; Incera, Elodie; ... (2012). Fracture risk and zoledronic acid therapy in men with osteoporosis. New England journal of medicine NEJM, 367(18), pp. 1714-23. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1204061
Eastell, Richard; Black, Dennis M; Boonen, Steven; Adami, Silvano; Felsenberg, Dieter; Lippuner, Kurt; Cummings, Steven R; Delmas, Pierre D; Palermo, Lisa; Mesenbrink, Peter; Cauley, Jane A (2009). Effect of once-yearly zoledronic acid 5 mg on fracture risk and change in femoral neck bone mineral density. Journal of clinical endocrinology and metabolism, 94(9), pp. 3215-3225. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2008-2765
Boonen, Steven; Sellmeyer, Deborah E; Lippuner, Kurt; Orlov-Morozov, Alexander; Abrams, Ken; Mesenbrink, Peter; Eriksen, Erik F; Miller, Paul D (2008). Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women. Kidney international, 74(5), pp. 641-8. New York, N.Y.: Nature Publishing Group 10.1038/ki.2008.193
